The Hip disability and Osteoarthritis Outcome Score (HOOS) is a 40-item patient-reported outcome (PRO) tool that has provided invaluable information related to subjective pain and function for patients with hip osteoarthritis (OA) and those undergoing total hip arthroplasty (THA). 23 However, while the full version of the HOOS allows for the specific domains of Pain, Symptoms, Activities of Daily Living, Sports and Recreation, and Quality of Life, the length of the tool has been a barrier to incorporating its routine use into clinical practice. With impending mandatory physician quality reporting for arthroplasty surgeons, Lyman et al 16 recently validated the HOOS-Joint Replacement (HOOS, JR). Consisting of 6 items from the full HOOS, the HOOS, JR is an efficient and responsive tool that provides clinicians with a global score to assess postoperative hip arthroplasty outcomes. 16 However, because the HOOS, JR was developed using a cohort of patients undergoing hip arthroplasty with an average age of 64 years, it is unlikely that the HOOS, JR would demonstrate similar psychometric properties if administered to younger, more active patients undergoing hip preservation.
There are clear advantages to having an efficient, valid, and responsive global PRO measure as meaningful clinical data can be generated with less burden to the patient, surgeon, and clinical staff. Furthermore, efficient global PRO scores may be more easily incorporated into the patient's electronic health record. Despite these advantages, to date, there is no single PRO tool validated for use across hip-related subspecialties. PRO administered to patients undergoing hip preservation. On the contrary, PRO tools such as the International Hip Outcome Tool (iHOT) and Hip Outcome Score (HOS) have been validated in the hip preservation population but not in the OA or THA population. 17, 19 The creation of a single PRO platform validated across hip preservation, OA, and THA populations may reduce barriers and streamline the routine collection of PROs in clinical practice.
As such, the purpose of this study was to develop a PRO platform by augmenting the HOOS, JR with additional questions from the full version of the HOOS and to assess the validity and responsiveness of this tool in a hip preservation population. We hypothesized that when administered to a hip preservation population, the augmented HOOS, JR (termed the HOOS global ) would demonstrate superior psychometric properties when compared with the HOOS, JR and other PRO tools that were originally developed for the OA and/or THA populations.
METHODS

Patients
From an institutional review board-approved multicenter prospective cohort (Academic Network of Conservational Hip Outcomes Research [ANCHOR], Washington University in St Louis protocol #201107167), we identified 304 consecutive patients undergoing periacetabular osteotomy (PAO) (243 female, 61 male; mean age, 24.7 6 9.4 years) with a minimum 1-year follow-up and complete preoperative and postoperative PRO data. All patients underwent PAO for hip dysplasia, with a subset undergoing concomitant procedures to address cam (n = 16), pincer (n = 2), or combined deformities (n = 3). We included all patients who had consented to participate in the study protocol, and patients were not excluded based on age, sex, race, or the presence of concomitant injuries. In addition to the HOOS, patients routinely completed the University of California, Los Angeles (UCLA) 32 activity scale and modified Harris Hip Score (mHHS) 26 questionnaires both before and after surgery. From the full version of the HOOS, the HOOS-JR, 16 HOOS-Physical Function Short form (HOOS-PS), 7 and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 4 scores were calculated.
Item Selection
To develop the HOOS global , we first identified individual items from the HOOS that were not included in the HOOS, JR for which a percentage of patients reported persistent postoperative difficulty. Items with \33% of patients with postoperative responses of ''none'' were selected for possible inclusion in the HOOS global , meaning that at least two-thirds of patients continued to report pain or difficulty with that item at a minimum of 1 year after PAO. This was done to ensure the face and content validity of the HOOS global . Items with which relatively few patients reported pain or difficulty would not discriminate between patients with a poor or good outcome, and by eliminating such items, the face and content validity of the HOOSglobal would be maintained. Once potential additional items were identified, we applied a Rasch measurement model to the stacked dataset using both the HOOS, JR and HOOS global . 25, 28, 29 Because each item has its own distinct set of category descriptors, the analysis was conducted using the Rasch partial credit model available in Rasch Measurement Software version 3.81.0 (Winsteps). 18, 30 Details regarding the methods used in the Rasch analysis, item inclusion and exclusion, and comparative results of the HOOS, JR and HOOS global can be found in the accompanying online Appendix.
We then calculated the HOOS global score associated with the patient acceptable symptom state (PASS). The PASS represents the postoperative threshold value of a given PRO instrument that is associated with the majority of patients with postoperative scores above the PASS threshold who are satisfied with their surgical procedure. 10 To do so, we employed methods similar to those recently used to calculate the PASS for the International Knee Documentation Committee (IKDC) subjective knee form and Knee injury and Osteoarthritis Outcome Score (KOOS) after anterior cruciate ligament reconstruction. 20 At the most recent postoperative follow-up visit, patients were asked if they were satisfied with their hip surgery with the options of either ''yes'' or ''no.'' We then utilized a receiver operating characteristic (ROC) curve to determine if a PASS threshold for the HOOS global could be identified. The PASS threshold was determined by calculating the Youden index, 31 which is a product of the sensitivity and specificity for a given outcome score, and the PASS threshold was the combination of sensitivity and specificity with the greatest Youden index.
Comparison of HOOS global , HOOS, JR, and Other Hip PRO Instruments
The responsiveness and presence of floor and ceiling effects with the HOOS global in comparison with the HOOS, JR and other PRO tools were then evaluated using the previously described methods. 11 The responsiveness of the HOOS global was also assessed by determining if the HOOS global was able to detect expected differences between patients' preoperative and postoperative scores. Responsiveness has been defined as a PRO tool's ability to detect meaningful or clinically important changes. 12 Responsiveness was assessed using 3 commonly used methods: effect size (ES), standardized response mean (SRM), and relative efficiency (RE). 11, 13, 24 The ES is the mean preoperative to postoperative change divided by the SD of the preoperative scores, and an ES .0.8 is considered large. 6, 11 The SRM is the preoperative to postoperative change divided by the SD of the change scores for that particular PRO tool, 12 ).
12,13 RE values .1 are indicative of the HOOS global being more responsive than the other PRO tools. The presence of a floor or ceiling effect was defined using the threshold of 15% of patients reporting either the worst possible or best possible scores, respectively.
14 A ceiling effect is present when more than 15% of the sampled patients report the best possible score, and conversely, a floor effect is present when more than 15% of the sampled patients demonstrate the worst possible score. Neither floor nor ceiling effects are ideal as both are indicative of a scoring system that can either not discriminate between an extremely poor result and a poor result (floor effect) or between an excellent result and a good result (ceiling effect). We have previously observed marked postoperative ceiling effects with OA-and/or THA-based PRO tools in this patient population, and 1-tailed chi-square tests were used to determine if the prevalence of maximum possible HOOS global postoperative scores differed from the other PRO tools included in this study (HOOS, JR, HOOS-PS, WOMAC, UCLA, and mHHS).
RESULTS
Based on the item selection methods and Rasch analysis results, 2 additional items were identified from the full version of the HOOS that met the criteria for inclusion in the HOOS global : question P1: ''How often is your hip painful?'' and question Q1: ''How often are you aware of your hip?'' (Figure 1 ). The raw HOOS global score was then determined by summing the responses to the original 6 HOOS, JR items and questions P1 and Q1. The scaled HOOS global score was determined using the logit conversion table (Figure 2) .
At a mean follow-up of 4.0 6 1.5 years, the HOOS global and all other PRO scores significantly improved from the preoperative visit (Tables 1 and 2 ). While all PRO tools including the HOOS global exceeded the 15% threshold for postoperative ceiling effects (the HOOS global had a 16% prevalence of maximum scores), the HOOS global had significantly fewer maximum postoperative scores than the HOOS, JR (P \ .0001), HOOS-PS (P \ .0001), WOMAC (P = .02), UCLA (P = .0002), and mHHS (P = .04) ( Table  1) 
DISCUSSION
The purpose of this study was to develop a PRO platform by augmenting the HOOS, JR with additional questions from the full version of the HOOS and to compare the validity and responsiveness of this tool to other PRO tools in a hip preservation population. The results by and large supported our hypothesis that the HOOS global would demonstrate superior psychometric properties when compared with the HOOS, JR and other PRO tools that were originally developed for the OA and/or THA populations. By adding 2 additional items related to how often the patient 
Function, daily lliving
The following questions concern your physical function. By this we mean your ability to move around and to look after yourself. For each of the following activities, please indicate the degree of difficulty you have experienced in the last week due to your hip. has pain in the involved hip and how often the patient is aware of the hip significantly lessened the prevalence of patients with perfect postoperative scores. The HOOS, JR provides surgeons with a valid and efficient method to quantify postoperative outcomes after hip arthroplasty 16 ; however, the HOOS, JR does not appear to be appropriate for use with the hip preservation population that has undergone PAO, as a large ceiling effect was noted. This finding was not unique to the HOOS, JR as large ceiling effects were also present for the HOOS-PS, WOMAC, UCLA, mHHS, and 5 HOOS subscales after PAO. Not only did the HOOS global alleviate some of the psychometric limitations of other OA-based PRO instruments, but the interpretation of the HOOS global results can also be put in a clinical context, with postoperative scores 62.5 being associated with patients achieving the PASS.
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HOOSglobal SCORING INSTRUCTIONS
The HOOSglobal was developed from the original versions of the Hip dysfunction and Osteoarthritis Outcome Score (HOOS) and HOOS, JR surveys and contains 8 items from the original surveys.Items are coded from 0 to 4, none to extreme respectively.
HOOSglobal is scored by summing the raw response (range 0-32) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents complete hip disability and 100 represents perfect hip health. Figure 2 . HOOS global scoring instructions. All outcome tools exceeded the 15% ceiling effect threshold postoperatively; however, the HOOS global had significantly fewer maximum scores postoperatively than the other patient-reported outcome tools (P \ .04 for all paired comparisons). The PRO instruments included in the current study were initially created and validated largely in patients with hip OA and those undergoing THA 2, 4, 8, 23 and have proven to be effective measurement options for their target patient populations. Our results are similar to other previous reports that have also questioned the use of OA-related PRO instruments in the hip preservation population. In a systematic review, Lodhia et al 15 reported notable ceiling effects with the WOMAC when used with femoroacetabular impingement and labral lesions. Similarly, Aprato et al 3 reported that 14% of patients with good to excellent mHHS scores 1 year after hip arthroscopic surgery were dissatisfied with their outcome, which may have been the result of a ceiling effect in this younger, more active patient population.
The goal of this work was not to supplant the HOOS, JR but rather to build upon it to reduce barriers to routine PRO collection in the clinical setting. The principal advantage of using the HOOS global as a PRO platform is its versatility across a variety of hip patient populations, thus reducing some of the burden to an orthopaedic practice associated with routine PRO collection. The 8 HOOS global questions can be scored differently for different patient subsets. All 8 questions can be used to generate a HOOS global instrument for the hip preservation population, while the original 6 HOOS, JR questions can be scored for patients with latestage OA and/or undergoing THA. Unlike the current available methods of using multiple PRO tools for the hip preservation and arthroplasty subsets of patients, front office staff would not need to differentiate which hip PRO questionnaire to give an individual patient. For example, the front office staff for a clinician who normally sees both hip preservation and OA patients during the course of a clinic day would not have to determine which PRO tool to give each patient but rather could use the HOOS global for adult hip patients. Similarly, being able to use the HOOS global could alleviate the complexities of collecting hip-related PROs in multisubspecialty practices. Perhaps most important, the 8 questions of the HOOS global take less than 5 minutes to complete, thereby minimizing the burden to the patient as well as reducing the likelihood that PRO collection will dramatically alter patient flow during the course of an average clinic day.
While the HOOS global may offer a single platform to reduce barriers to routine clinical PRO collection, we are not suggesting that this tool is a ''silver bullet.'' The HOOS global significantly reduced the prevalence of perfect postoperative scores when compared with OA/THA PRO tools; however, the 16% prevalence of perfect scores was above the 15% ceiling effect threshold. As such, future studies are necessary to determine if the HOOS global is an acceptable alternative to hip preservation-specific instruments, especially in athletic patients undergoing hip arthroscopic surgery. Recommended PRO tools are available through the American Academy of Orthopaedic Surgeons (AAOS) website; however, while the HOOS and HOOS, JR have been recommended for use in patients with hip OA, 1 the AAOS has not given guidance as to what tool(s) is or are best suited for the assessment of patients before and after hip preservation procedures. Multiple tools exist, including the iHOT, 19 HOS, 21 Nonarthritic Hip Score, 5 Hip Sports Activity Scale, 22 Copenhagen Hip and Groin Outcome Score, 27 and Core Outcome Measures Index-Hip, 9 among others. While these have been utilized in the hip preservation literature, there is limited head-to-head comparative information related to the clinimetric and psychometric properties of these instruments. Also, it remains unclear if these hip preservation-specific tools could be utilized as patients transition from hip preservation to OA to THA as they have not been validated in the OA or THA populations. This study is not without limitations. First, an a priori power analysis was not performed as part of this study. Rather, we used liberal inclusion and exclusion criteria to ensure that the development of the HOOS global could be generalized to the broad PAO population. There is potential for a selection bias in that the study was performed with patients who elected to participate in a research study; however, because of the liberal inclusion/exclusion criteria, there was little opportunity for selection bias on behalf of the researchers. Second, hip preservation-specific PRO instruments were not included as part of this multicenter prospective study. As such, we were unable to directly compare the responsiveness between OA-and hip preservation-specific PRO instruments. At the time that the multicenter registry was initiated, the psychometric properties of hip preservation-specific PRO tools had not yet been fully vetted, and because one of the primary goals of the registry is to evaluate long-term outcomes and the progression to OA, OAbased PRO tools were utilized. Third, the HOOS global was used in a PAO population in the current study, and the HOOS, JR has been validated in the THA population. While these 2 patient populations represent the ''anchors'' on the continuum of posttraumatic OA, the validity of the HOOS global platform has not been evaluated in either those with mild to moderate hip OA or potentially younger and more active patients undergoing hip arthroscopic surgery and/or with femoroacetabular impingement. Future studies are necessary to assess the test-retest reliability of the HOOS global and to determine if the current results are generalizable to additional patient groups.
In conclusion, the HOOS, JR and other OA-based PRO instruments demonstrated large ceiling effects in a hip preservation population after PAO. While we can conclude that OA-based PRO tools may not be the most appropriate methods to quantify outcomes after hip preservation procedures because of the large ceiling effects that were observed, by including 2 additional HOOS questions, the HOOS global is a valid and responsive PRO tool after PAO and may potentially provide the orthopaedic community with a PRO platform to be used across hip-related subspecialties. Finally, postoperative HOOS global scores 62.5 were associated with patients achieving the PASS.
